Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Urinary Bladder Neoplasms: HELP
Toni K. Choueiri
Based on 32 articles published since 2009
(Why 32 articles?)
||||
Expertise Level
The expertise of Toni K. Choueiri ranks in the Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Choueiri, Toni K   ·   Choueiri, T   ·   Choueiri, Toni   ·   Choueiri, T K
Work Locations
Details
Most likely:    Harvard University Boston   Contact    
2018
  • University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL. Electronic address: · Ontario Clinical Oncology Group, Hamilton, ON. · Memorial Sloan Kettering Cancer Center, New York, NY. · Dana-Farber Cancer Institute, Boston, MA. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · Dankook University Hospital, Dankook University College of Medicine, Cheonan, South Korea. · Genentech Inc, South San Francisco, CA. · Pubmed 29706503
  • David J. Vaughn, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA · Joaquim Bellmunt and Toni K. Choueiri, Dana-Farber Cancer Institute, Boston, MA · Yves Fradet, CHU de Québec-Université Laval, Quebec City, Quebec, Canada · Jae Lyun Lee, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Republic of Korea · Lawrence Fong, University of California, San Francisco, San Francisco · David I. Quinn, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA · Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV · Miguel A. Climent, Fundación Instituto Valenciano de Oncología, Valencia, Spain · Daniel P. Petrylak, Smilow Cancer Hospital, Yale University, New Haven, CT · Andrea Necchi, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale dei Tumori, Milan · Cora N. Sternberg, San Camillo and Forlanini Hospitals, Rome, Italy · Winald Gerritsen, Radboud University Medical Center, Nijmegen · Ronald de Wit, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands · Howard Gurney, Westmead Hospital and Macquarie University, Sydney, New South Wales, Australia · Stephane Culine, Hôpital Saint-Louis, Paris, France · Yabing Mai, Haojie Li, and Rodolfo F. Perini, Merk & Co., Inc., Kenilworth, NJ · and Dean F. Bajorin, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 29590008
  • Division of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, 45 Francis St, ASB II-3, Boston, MA, USA. · Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Department of Urology, University Hospital Frankfurt, Frankfurt Am Main, Germany. · Department of Urology and Neuro-Urology, Marien Hospital Herne, Ruhr-University Bochum, Herne, Germany. · Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Division of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, 45 Francis St, ASB II-3, Boston, MA, USA. · Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Pubmed 29948050
  • Division of Urological Surgery, Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. · Division of Urological Surgery, Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Vattikuti Urology Institute (VUI), VUI Center for Outcomes Research Analytics and Evaluation, Henry Ford Hospital, Detroit, MI. · Division of Urological Surgery, Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 29454591
  • Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Henry Ford Hospital, Vattikuti Institute of Urology, Center for Outcomes Research, Analytics and Evaluation, Detroit, MI. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Brigham and Women's Hospital, Boston, MA. · Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 29277584
2017
  • Bladder Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Department of Medical Oncology, Ankara University School of Medicine, Ankara, Turkey. · Bladder Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Department of Urology, Tan Tock Seng Hospital, Singapore. · Bladder Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Bladder Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: · Pubmed 29198325
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: · Pubmed 29183736
  • Division of Urological Surgery, Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Urology, Pitié-Salpêtriére Hospital, Pierre and Marie Curie University, Paris, France. · Department of Urology, Marien Hospital Herne, Ruhr-University Bochum, Herne, Germany. · Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan. · Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Pubmed 28743155
  • Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, Massachusetts. · Department of Biostatistics, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, Massachusetts. · Department of Pathology, Brigham and Women's Cancer Center, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, Massachusetts. · Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. · Department of Pathology, Vall d'Hebron Hospital, Barcelona, Spain. · Department of Urology, Vall d'Hebron Hospital, Barcelona, Spain. · Department of Medical Oncology, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. · Department of Pathology, Brigham and Women's Cancer Center, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. · Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. Electronic address: · Pubmed 28487100
  • Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI, USA. · Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: · Pubmed 28412065
2016
  • City of Hope Comprehensive Cancer Center, Duarte, CA · Huntsman Cancer Institute, University of Utah, Salt Lake City, UT. · Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH. · Dana-Farber Cancer Institute, Boston, MA. · Pubmed 26786913
  • Departement of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Departement of Medical Oncology, Brigham and Women's Cancer Center, Brigham and Women's Cancer Center, Boston, MA 02115, USA. · Departement of Medical Oncology, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA. · The Eli and Edythe L. Broad Institute, 415 Main Street, Cambridge, MA 02142, USA. · Departement of Medical Oncology, University of Alabama at Birmingham (UAB), 1720 2nd Avenue S, Birmingham, AL 35233, USA. · Pubmed 27351382
  • Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston MA, USA. · Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · University Hospital del Mar-IMIM, Barcelona, Spain. · Pubmed 27283319
  • Thomas Seisen, Maxine Sun, Jeffrey J. Leow, Mark A. Preston, Alexander P. Cole, Francisco Gelpi-Hammerschmidt, Nawar Hanna, Christian P. Meyer, Adam S. Kibel, Stuart R. Lipsitz, Paul L. Nguyen, and Quoc-Dien Trinh, Brigham and Women's Hospital · and Joaquim Bellmunt and Toni K. Choueiri, Dana-Farber Cancer Institute, Boston, MA. · Pubmed 27269944
  • University of Alabama-Birmingham Comprehensive Cancer Center, Birmingham, Alabama. Electronic address: · McMaster University, Hamilton, Ontario, Canada. · Memorial Sloan Kettering Cancer Center, New York, New York. · Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · University Federico II, Naples, Italy. · Pubmed 26292040
2015
  • University of Alabama at Birmingham (UAB) Comprehensive Cancer Center, 1720 2nd Ave. S., Birmingham, AL 35294, USA. · Bladder Cancer Institute, Dana Farber Cancer Institute, Dana-Farber/Brigham and Women's Cancer Center, Boston, 450, Brookline Ave, MA 02215, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Padiglioni Flajani, 1st Floor, Circonvallazione Gianicolense 87, Rome 00152, Italy. Electronic address: · Pubmed 25836940
  • Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. · VUI Center for Outcomes Research, Analytics, and Evaluation, Henry Ford Health System, Detroit, MI. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 26320810
  • Bladder Cancer Center, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, University Hospital de Mar-IMIM, Barcelona, Spain. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · University of Athens and Hellenic Co-operative Oncology Group, Athens, Greece. · Center for Molecular Oncologic Pathology, Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts. · The Johns Hopkins University School of Medicine, Baltimore, Maryland. · Hospital de Mar Research Institute-IMIM, Barcelona, Spain. · Hospital Parc Tauli, Sabadell, Spain. · IIS-Fundacion Jimenez Diaz, Madrid, Spain. · Memorial Sloan Kettering Cancer Center, New York City, New York. · Pubmed 25720673
2014
  • UAB Comprehensive Cancer Center, Birmingham, AL. · University Hospital del Mar-IMIM, Barcelona, Spain. · Memorial Sloan Kettering Cancer Center, New York, NY. · Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA. · Heinrich Heine University, Dusseldorf, Germany. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · University Federico II, Naples, Italy. · Institut de Recherche Pierre Fabre, Boulogne, France. · Fox Chase Cancer Center, Philadelphia, PA. · Princess Margaret Hospital, Toronto, ON, Canada. · Sunnybrook Odette Cancer Centre, Toronto, ON, Canada. · University of North Carolina, Chapel Hill, NC. · Tisch Cancer Center Institute, Mount Sinai School of Medicine, New York, NY. · McMaster University, Hamilton, ON, Canada. · Pubmed 25035282
  • Harvard School of Public Health, Harvard University, Boston, MA, USA; Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Boston, MA, USA. · Harvard School of Public Health, Harvard University, Boston, MA, USA. · Department of Pathology, University of Miami Miller School of Medicine, Miami, FL, USA. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA. · Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Boston, MA, USA. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA; University Hospital del Mar-IMIM, Barcelona, Spain. Electronic address: · Pubmed 24018020
  • Toni K. Choueiri, Susanna Jacobus, Joaquim Bellmunt, Angela Qu, Edward C. Stack, Sabina Signoretti, Meghara Walsh, Graeme Steele, Michelle Hirsch, Christopher J. Sweeney, Mary-Ellen Taplin, Adam S. Kibel, Katherine M. Krajewski, Philip W. Kantoff, Robert W. Ross, and Jonathan E. Rosenberg, Dana-Farber Cancer Institute and Brigham and Women's Hospital · Christopher Tretter, Lahey Clinic, Burlington · Glenn J. Bubley, Beth Israel Deaconess Medical Center, Boston, MA · Leonard J. Appleman, University of Pittsburgh, Pittsburgh, PA · and Jonathan E. Rosenberg, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 24821883
  • Department of Internal Medicine/Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT. · University Hospital del Mar-IMIM, Barcelona, Spain. · Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT. · Department of Medicine/Solid Tumor Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA. · Comprehensive Cancer Centers of Nevada, Las Vegas, NV. · Institut de Recherche Pierre Fabre, Boulogne, France. · Department of Urology, Heinrich Heine University, Dusseldorf, Germany. · Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA. · Department of Medicine, Sunnybrook Odette Cancer Centre, Toronto, ON, Canada. · Department of Medicine, Princess Margaret Hospital, Toronto, ON, Canada. · Department of Medicine/Hematology and Medical Oncology, Tisch Cancer Center Institute, Mount Sinai School of Medicine, New York, NY. · Department of Internal Medicine/Medical Oncology, Yale University Cancer Center, New Haven, CT. · Department of Oncology, Wayne State University, Detroit, MI. · Department of Medicine/Hematology-Oncology, UAB Comprehensive Cancer Center, Birmingham, AL. · Department of Medicine/Hematology-Oncology, Oregon Health & Science University, Knight Cancer Institute, Portland, OR. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Medicine/Hematology-Oncology, Memorial Sloan Kettering Cancer Center, New York, NY. · Department of Medicine/Hematology-Oncology, UAB Comprehensive Cancer Center, Birmingham, AL. Electronic address: · Pubmed 24220220
  • Fox Chase Cancer Center, Philadelphia, PA · Thomas Jefferson University Hospital, Philadelphia, PA. · Memorial Sloan Kettering Cancer Center, New York, NY. · Fox Chase Cancer Center, Philadelphia, PA. · Dana-Farber Cancer Institute, Boston, MA. · Pubmed 25385730
2014
  • Departments of 1Medical Oncology and 2Biostatistics and Computational Biology, 3Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute; Departments of 4Medicine and 5Pathology, Brigham and Women's Hospital, Harvard Medical School; 6Division of Hematology/Oncology, Massachusetts General Hospital, Boston; 7Broad Institute of Harvard and MIT; 8Department of Biology, Whitehead Institute for Biomedical Research; 9Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts; and 10Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York. · Pubmed 24625776
  • Dana-Farber Cancer Institute, Boston, Massachusetts; University of Rochester, Rochester, New York. · Pubmed 24846059
  • Authors' Affiliations: Departments of Biostatistics and Computational Biology, and Medical Oncology; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute; Department of Biostatistics, Harvard School of Public Health; Department of Pathology; Translational Medicine Division, Brigham and Women's Hospital, Boston; Broad Institute of Harvard and MIT, Cambridge, Massachusetts; Sidney Kimmel Cancer Center; Department of Pathology, Johns Hopkins University, Baltimore, Maryland; Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York; and Hospital del Mar Research Institute-IMIM, Barcelona; and Hospital Parc Tauli, Sabadell, Spain. · Pubmed 24486590
2013
  • Bladder Cancer Center at the Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, 450 Brookline Avenue, 1230 DANA, Boston, MA 02215, USA. · Pubmed 24129239
2012
  • Department of Imaging, Dana-Farber Cancer Institute, MA, USA. · Pubmed 22176867
  • Division of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Pubmed 22482778
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 32 total) written by Toni K. Choueiri about Urinary Bladder Neoplasms:

  • Nomogram to Assess the Survival Benefit of New Salvage Agents for Metastatic Urothelial Carcinoma in the Era of Immunotherapy. 2018
  • Health-Related Quality-of-Life Analysis From KEYNOTE-045: A Phase III Study of Pembrolizumab Versus Chemotherapy for Previously Treated Advanced Urothelial Cancer. 2018
  • Characterizing trends in treatment modalities for localized muscle-invasive bladder cancer in the pre-immunotherapy era. 2018
  • The effect of treatment at minority-serving hospitals on outcomes for bladder cancer. 2018
  • Comparative effectiveness of robot-assisted vs. open radical cystectomy. 2018
  • ERCC1 as a prognostic factor for survival in patients with advanced urothelial cancer treated with platinum based chemotherapy: A systematic review and meta-analysis. 2017
  • Immunotherapy in the Elderly. 2017
  • Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology. 2017
  • Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications. 2017
  • Comparative Effectiveness of Trimodal Therapy Versus Radical Cystectomy for Localized Muscle-invasive Urothelial Carcinoma of the Bladder. 2017
Show List of Full Article Records
Google Searches

Learn more about Toni K. Choueiri using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Harvard University Boston
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Harvard University Boston
2018
  • University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL. Electronic address: · Ontario Clinical Oncology Group, Hamilton, ON. · Memorial Sloan Kettering Cancer Center, New York, NY. · Dana-Farber Cancer Institute, Boston, MA. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · Dankook University Hospital, Dankook University College of Medicine, Cheonan, South Korea. · Genentech Inc, South San Francisco, CA. · Pubmed 29706503
  • David J. Vaughn, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA · Joaquim Bellmunt and Toni K. Choueiri, Dana-Farber Cancer Institute, Boston, MA · Yves Fradet, CHU de Québec-Université Laval, Quebec City, Quebec, Canada · Jae Lyun Lee, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Republic of Korea · Lawrence Fong, University of California, San Francisco, San Francisco · David I. Quinn, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA · Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV · Miguel A. Climent, Fundación Instituto Valenciano de Oncología, Valencia, Spain · Daniel P. Petrylak, Smilow Cancer Hospital, Yale University, New Haven, CT · Andrea Necchi, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale dei Tumori, Milan · Cora N. Sternberg, San Camillo and Forlanini Hospitals, Rome, Italy · Winald Gerritsen, Radboud University Medical Center, Nijmegen · Ronald de Wit, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands · Howard Gurney, Westmead Hospital and Macquarie University, Sydney, New South Wales, Australia · Stephane Culine, Hôpital Saint-Louis, Paris, France · Yabing Mai, Haojie Li, and Rodolfo F. Perini, Merk & Co., Inc., Kenilworth, NJ · and Dean F. Bajorin, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 29590008
  • Division of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, 45 Francis St, ASB II-3, Boston, MA, USA. · Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Department of Urology, University Hospital Frankfurt, Frankfurt Am Main, Germany. · Department of Urology and Neuro-Urology, Marien Hospital Herne, Ruhr-University Bochum, Herne, Germany. · Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Division of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, 45 Francis St, ASB II-3, Boston, MA, USA. · Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Pubmed 29948050
  • Division of Urological Surgery, Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. · Division of Urological Surgery, Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Vattikuti Urology Institute (VUI), VUI Center for Outcomes Research Analytics and Evaluation, Henry Ford Hospital, Detroit, MI. · Division of Urological Surgery, Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 29454591
  • Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Henry Ford Hospital, Vattikuti Institute of Urology, Center for Outcomes Research, Analytics and Evaluation, Detroit, MI. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Brigham and Women's Hospital, Boston, MA. · Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 29277584
2017
  • Bladder Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Department of Medical Oncology, Ankara University School of Medicine, Ankara, Turkey. · Bladder Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Department of Urology, Tan Tock Seng Hospital, Singapore. · Bladder Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Bladder Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: · Pubmed 29198325
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: · Pubmed 29183736
  • Division of Urological Surgery, Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Urology, Pitié-Salpêtriére Hospital, Pierre and Marie Curie University, Paris, France. · Department of Urology, Marien Hospital Herne, Ruhr-University Bochum, Herne, Germany. · Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan. · Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Pubmed 28743155
  • Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, Massachusetts. · Department of Biostatistics, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, Massachusetts. · Department of Pathology, Brigham and Women's Cancer Center, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, Massachusetts. · Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. · Department of Pathology, Vall d'Hebron Hospital, Barcelona, Spain. · Department of Urology, Vall d'Hebron Hospital, Barcelona, Spain. · Department of Medical Oncology, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. · Department of Pathology, Brigham and Women's Cancer Center, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. · Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. Electronic address: · Pubmed 28487100
  • Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI, USA. · Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: · Pubmed 28412065
2016
  • City of Hope Comprehensive Cancer Center, Duarte, CA · Huntsman Cancer Institute, University of Utah, Salt Lake City, UT. · Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH. · Dana-Farber Cancer Institute, Boston, MA. · Pubmed 26786913
  • Departement of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Departement of Medical Oncology, Brigham and Women's Cancer Center, Brigham and Women's Cancer Center, Boston, MA 02115, USA. · Departement of Medical Oncology, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA. · The Eli and Edythe L. Broad Institute, 415 Main Street, Cambridge, MA 02142, USA. · Departement of Medical Oncology, University of Alabama at Birmingham (UAB), 1720 2nd Avenue S, Birmingham, AL 35233, USA. · Pubmed 27351382
  • Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston MA, USA. · Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · University Hospital del Mar-IMIM, Barcelona, Spain. · Pubmed 27283319
  • Thomas Seisen, Maxine Sun, Jeffrey J. Leow, Mark A. Preston, Alexander P. Cole, Francisco Gelpi-Hammerschmidt, Nawar Hanna, Christian P. Meyer, Adam S. Kibel, Stuart R. Lipsitz, Paul L. Nguyen, and Quoc-Dien Trinh, Brigham and Women's Hospital · and Joaquim Bellmunt and Toni K. Choueiri, Dana-Farber Cancer Institute, Boston, MA. · Pubmed 27269944
  • University of Alabama-Birmingham Comprehensive Cancer Center, Birmingham, Alabama. Electronic address: · McMaster University, Hamilton, Ontario, Canada. · Memorial Sloan Kettering Cancer Center, New York, New York. · Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · University Federico II, Naples, Italy. · Pubmed 26292040
2015
  • University of Alabama at Birmingham (UAB) Comprehensive Cancer Center, 1720 2nd Ave. S., Birmingham, AL 35294, USA. · Bladder Cancer Institute, Dana Farber Cancer Institute, Dana-Farber/Brigham and Women's Cancer Center, Boston, 450, Brookline Ave, MA 02215, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Padiglioni Flajani, 1st Floor, Circonvallazione Gianicolense 87, Rome 00152, Italy. Electronic address: · Pubmed 25836940
  • Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. · VUI Center for Outcomes Research, Analytics, and Evaluation, Henry Ford Health System, Detroit, MI. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 26320810
  • Bladder Cancer Center, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, University Hospital de Mar-IMIM, Barcelona, Spain. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · University of Athens and Hellenic Co-operative Oncology Group, Athens, Greece. · Center for Molecular Oncologic Pathology, Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts. · The Johns Hopkins University School of Medicine, Baltimore, Maryland. · Hospital de Mar Research Institute-IMIM, Barcelona, Spain. · Hospital Parc Tauli, Sabadell, Spain. · IIS-Fundacion Jimenez Diaz, Madrid, Spain. · Memorial Sloan Kettering Cancer Center, New York City, New York. · Pubmed 25720673
2014
  • UAB Comprehensive Cancer Center, Birmingham, AL. · University Hospital del Mar-IMIM, Barcelona, Spain. · Memorial Sloan Kettering Cancer Center, New York, NY. · Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA. · Heinrich Heine University, Dusseldorf, Germany. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · University Federico II, Naples, Italy. · Institut de Recherche Pierre Fabre, Boulogne, France. · Fox Chase Cancer Center, Philadelphia, PA. · Princess Margaret Hospital, Toronto, ON, Canada. · Sunnybrook Odette Cancer Centre, Toronto, ON, Canada. · University of North Carolina, Chapel Hill, NC. · Tisch Cancer Center Institute, Mount Sinai School of Medicine, New York, NY. · McMaster University, Hamilton, ON, Canada. · Pubmed 25035282
  • Harvard School of Public Health, Harvard University, Boston, MA, USA; Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Boston, MA, USA. · Harvard School of Public Health, Harvard University, Boston, MA, USA. · Department of Pathology, University of Miami Miller School of Medicine, Miami, FL, USA. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA. · Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Boston, MA, USA. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA; University Hospital del Mar-IMIM, Barcelona, Spain. Electronic address: · Pubmed 24018020
  • Toni K. Choueiri, Susanna Jacobus, Joaquim Bellmunt, Angela Qu, Edward C. Stack, Sabina Signoretti, Meghara Walsh, Graeme Steele, Michelle Hirsch, Christopher J. Sweeney, Mary-Ellen Taplin, Adam S. Kibel, Katherine M. Krajewski, Philip W. Kantoff, Robert W. Ross, and Jonathan E. Rosenberg, Dana-Farber Cancer Institute and Brigham and Women's Hospital · Christopher Tretter, Lahey Clinic, Burlington · Glenn J. Bubley, Beth Israel Deaconess Medical Center, Boston, MA · Leonard J. Appleman, University of Pittsburgh, Pittsburgh, PA · and Jonathan E. Rosenberg, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 24821883
  • Department of Internal Medicine/Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT. · University Hospital del Mar-IMIM, Barcelona, Spain. · Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT. · Department of Medicine/Solid Tumor Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA. · Comprehensive Cancer Centers of Nevada, Las Vegas, NV. · Institut de Recherche Pierre Fabre, Boulogne, France. · Department of Urology, Heinrich Heine University, Dusseldorf, Germany. · Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA. · Department of Medicine, Sunnybrook Odette Cancer Centre, Toronto, ON, Canada. · Department of Medicine, Princess Margaret Hospital, Toronto, ON, Canada. · Department of Medicine/Hematology and Medical Oncology, Tisch Cancer Center Institute, Mount Sinai School of Medicine, New York, NY. · Department of Internal Medicine/Medical Oncology, Yale University Cancer Center, New Haven, CT. · Department of Oncology, Wayne State University, Detroit, MI. · Department of Medicine/Hematology-Oncology, UAB Comprehensive Cancer Center, Birmingham, AL. · Department of Medicine/Hematology-Oncology, Oregon Health & Science University, Knight Cancer Institute, Portland, OR. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Medicine/Hematology-Oncology, Memorial Sloan Kettering Cancer Center, New York, NY. · Department of Medicine/Hematology-Oncology, UAB Comprehensive Cancer Center, Birmingham, AL. Electronic address: · Pubmed 24220220
  • Fox Chase Cancer Center, Philadelphia, PA · Thomas Jefferson University Hospital, Philadelphia, PA. · Memorial Sloan Kettering Cancer Center, New York, NY. · Fox Chase Cancer Center, Philadelphia, PA. · Dana-Farber Cancer Institute, Boston, MA. · Pubmed 25385730
2014
  • Departments of 1Medical Oncology and 2Biostatistics and Computational Biology, 3Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute; Departments of 4Medicine and 5Pathology, Brigham and Women's Hospital, Harvard Medical School; 6Division of Hematology/Oncology, Massachusetts General Hospital, Boston; 7Broad Institute of Harvard and MIT; 8Department of Biology, Whitehead Institute for Biomedical Research; 9Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts; and 10Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York. · Pubmed 24625776
  • Dana-Farber Cancer Institute, Boston, Massachusetts; University of Rochester, Rochester, New York. · Pubmed 24846059
  • Authors' Affiliations: Departments of Biostatistics and Computational Biology, and Medical Oncology; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute; Department of Biostatistics, Harvard School of Public Health; Department of Pathology; Translational Medicine Division, Brigham and Women's Hospital, Boston; Broad Institute of Harvard and MIT, Cambridge, Massachusetts; Sidney Kimmel Cancer Center; Department of Pathology, Johns Hopkins University, Baltimore, Maryland; Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York; and Hospital del Mar Research Institute-IMIM, Barcelona; and Hospital Parc Tauli, Sabadell, Spain. · Pubmed 24486590
2013
  • Bladder Cancer Center at the Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, 450 Brookline Avenue, 1230 DANA, Boston, MA 02215, USA. · Pubmed 24129239
2012
  • Department of Imaging, Dana-Farber Cancer Institute, MA, USA. · Pubmed 22176867
  • Division of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Pubmed 22482778
6 Other Locations Show
Yearly article counts 05553822110
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.